Terms: = Lung cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
89 results:
1. Combined Inhibition of ezh2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
2. Long Non-coding RNA
Endo I; Amatya VJ; Kushitani K; Nakagiri T; Aoe K; Takeshima Y
Anticancer Res; 2023 Dec; 43(12):5367-5376. PubMed ID: 38030172
[TBL] [Abstract] [Full Text] [Related]
3. Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in lung Adenocarcinoma.
Saggese P; Pandey A; Alcaraz M; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Shirihai OS; Weisz A; Dubinett SM; Scafoglio C
Cancer Res; 2024 Jan; 84(2):305-327. PubMed ID: 37934116
[TBL] [Abstract] [Full Text] [Related]
4. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
[No Abstract] [Full Text] [Related]
5. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
6. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on cancer Therapies including Immunotherapy.
Shi Y; Shin DS
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
[TBL] [Abstract] [Full Text] [Related]
7. ezh2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacological inhibition of ezh2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Zhu Y; Zhang L; Song X; Zhang Q; Wang T; Xiao H; Yu L
Biochem Pharmacol; 2023 Apr; 210():115493. PubMed ID: 36898415
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of ezh2.
Duan Y; Yue K; Ye B; Chen P; Zhang J; He Q; Wu Y; Lai Q; Li H; Wu Y; Jing C; Wang X
Cell Death Dis; 2023 Feb; 14(2):149. PubMed ID: 36813772
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of the correlation between Zeste enhancer homolog 2 (ezh2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration.
Fan K; Zhang CL; Zhang BH; Gao MQ; Sun YC
Sci Rep; 2022 Oct; 12(1):16583. PubMed ID: 36195655
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptomic data exploration of consensus genes and molecular mechanisms between chronic obstructive pulmonary disease and lung adenocarcinoma.
Zhang S; Pang K; Feng X; Zeng Y
Sci Rep; 2022 Aug; 12(1):13214. PubMed ID: 35918384
[TBL] [Abstract] [Full Text] [Related]
12. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
13. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract] [Full Text] [Related]
14. The combined use of long non-coding RNA HOTAIR and polycomb group protein ezh2 as a prognostic marker of lung adenocarcinoma.
Iizuka T; Nagano H; Nomura K; Hiramatsu M; Motoi N; Mun M; Ishikawa Y
Cancer Treat Res Commun; 2022; 31():100541. PubMed ID: 35245884
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell lung cancer.
Gao C; Gu X; Chen Y; Zhou M; Jiang F; Zheng S
Med Sci Monit; 2021 Nov; 27():e932275. PubMed ID: 34719665
[TBL] [Abstract] [Full Text] [Related]
16. An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development.
Wang R; Liu J; Li K; Yang G; Chen S; Wu J; Xie X; Ren H; Pang Y
J Exp Clin Cancer Res; 2021 Oct; 40(1):318. PubMed ID: 34645486
[TBL] [Abstract] [Full Text] [Related]
17. Pleural mesothelioma (PM) - The status of systemic therapy.
Cui W; Popat S
Cancer Treat Rev; 2021 Nov; 100():102265. PubMed ID: 34399145
[TBL] [Abstract] [Full Text] [Related]
18. The Role of Tumor-related LncRNA PART1 in cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract] [Full Text] [Related]
19. LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma.
Fang P; Chen H; Ma Z; Han C; Yin W; Wang S; Zhu H; Xia W; Wang J; Xu L; Liu T; Yin R
Cancer Commun (Lond); 2021 Jul; 41(7):596-614. PubMed ID: 34105888
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
Tu Z; Chen X; Tian T; Chen G; Huang M
Aging (Albany NY); 2021 Feb; 13(5):7397-7415. PubMed ID: 33658396
[TBL] [Abstract] [Full Text] [Related]
[Next]
